We came across a bullish thesis on Collegium Pharmaceutical, Inc. on The Catholic Capitalist’s Substack by Logan Shearer. In this article, we will summarize the bulls’ thesis on COLL. Collegium Pharmaceutical, Inc.'s share was trading at $35.16 as of September 24th. COLL’s trailing and forward P/E were 32.92 and 4.87 respectively according to Yahoo Finance. Taysha Gene Therapies Inc. (TSHA) is ‘Market Perform’ on Rett Syndrome Therapy: JMP Securities Collegium Pharmaceuticals (COLL) represents a compelli ...